Congress orders study on infant heart monitors to prevent sudden death
S. 3712 — BO’s Act · Filed by Cindy Hyde-Smith (R-MS) · 4 cosponsors · Introduced Jan 28, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Secretary of Health and Human Services to study whether home cardiorespiratory monitors—devices that track an infant's heart rate, blood oxygen, and vital signs—can help prevent sudden unexpected infant death. The Secretary must report findings within one year, including evidence on device effectiveness, care models, insurance coverage criteria, and recommendations on whether insurers should cover these monitors. The bill benefits families with high-risk infants by potentially expanding access to monitoring technology.
Why we flagged it
The bill is a straightforward research mandate directing HHS to study infant monitoring technology and report on insurance coverage implications. It is not a regulatory change, appropriation, or industry carve-out—purely a fact-finding exercise with public-health intent.
What the text implies
- Study findings may influence private insurance underwriting standards for infant monitoring coverage, potentially creating market demand for cardiorespiratory monitor manufacturers.
- Report recommendations on public insurance coverage (Medicaid, CHIP) could trigger regulatory or policy changes affecting device reimbursement rates and access equity.
The full analysis lists 3 implications of this text.
Who stands to gain
medical device manufacturers (cardiorespiratory monitors); health insurance companies (if coverage expands)